Infliximab use in Crohn's disease: impact on health care resources in the UK.
OBJECTIVE: To quantify the impact of infliximab therapy on health care resource utilization in the UK. METHODS: A retrospective audit was undertaken at seven centres in the UK, which reviewed patient notes for a period of 6 months before and 6 months after an initial infliximab infusion. Details of...
主要な著者: | Jewell, D, Satsangi, J, Lobo, A, Probert, C, Forbes, A, Ghosh, S, Shaffer, J, Frenz, M, Drummond, H, Troy, G, Turner, S, Younge, L, Evans, L, Moosa, M, Rodgers-Gray, B, Buchan, S |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2005
|
類似資料
-
Infliximab in Crohn's disease
著者:: L. Rodrigo Sáez -
Infliximab in the Treatment of Crohn’s Disease
著者:: Brian Feagan
出版事項: (2000-01-01) -
Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
著者:: Hyder, SA, 等
出版事項: (2006) -
Molecular genetics of Crohn's disease: recent advances.
著者:: Satsangi, J, 等
出版事項: (1998) -
Predictors of response to infliximab in patients with fistulizing Crohn's disease Factores predictivos de respuesta a infliximab en pacientes con enfermedad de Crohn fistulizante
著者:: M. Luna-Chadid, 等
出版事項: (2004-06-01)